article thumbnail

Predictors of permanent pacemaker requirement in aortic stenosis patients undergoing self-expanding valve transcatheter aortic valve replacement using the cusp overlap technique

Frontiers in Cardiovascular Medicine

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV). Forty-seven received SEVs using COL, and 50 with CON techniques.

article thumbnail

Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis

Circulation: Cardiovascular Interventions

BACKGROUND:Current guidelines recommend surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and unfavorable iliofemoral access. Circulation: Cardiovascular Interventions, Ahead of Print.

article thumbnail

Early TAVR trial : Too early to call

Dr. S. Venkatesan MD

We know TAVI is in the striking distance , to literally take over most aortic valve interventions. Expected to improve with polymer valves) The latest trial to join the litereture is EARLY TAVR in October 2024 Here is a brief, personal comment about the paper for non-academic consumption. Look carefully at the 15th second of the video.

TAVR 52
article thumbnail

Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery

DAIC

The academic medical centers received three-star ratings in isolated coronary artery bypass grafting (CABG) and isolated mitral valve replacement and repair (MVRR) surgeries. Jersey Shore University Medical Center also received a three-star rating in isolated aortic valve replacement (AVR) surgery.

article thumbnail

Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: a Randomized Clinical Trial

Circulation

Background: Symptomatic severe aortic stenosis (AS) remains undertreated with high resultant mortality despite increased growth and availability of aortic valve replacement (AVR) since the advent of transcatheter therapies. The patient cohort had mean age of 7711 years, was 47% female, and had mean aortic valve area 0.80.1

Aortic 45
article thumbnail

Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement

Journal of the American Heart Association

BackgroundCurrent guidelines and expert consensus recommend lifelong single antiplatelet therapy for patients undergoing transcatheter aortic valve replacement who have no indication for anticoagulation or dual antiplatelet therapy. Journal of the American Heart Association, Ahead of Print.

article thumbnail

Association Between the Malnutrition Status and All‐Cause Mortality in Patients With Moderate and Severe Aortic Stenosis: A Prospective Cohort Study

Journal of the American Heart Association

BackgroundMalnutrition status is an important predictor of prognosis in patients after aortic valve replacement. However, the prognostic value of malnutrition status in patients with moderatetosevere aortic stenosis is unclear. Patients were grouped according to different nutritional status assessment methods.